생화학분자생물학회입니다.
Computational frameworks for enhanced extracellular vesicle biomarker discovery
작성자
Sungyong You작성일자
2026-03-19조회수
438![]() |
Name: Sungyong You ( Sungyong.You@csmc.edu ) | |
| 2025-present | Professor, Departments of Urology and Computational Biomedicine, Cedars-Sinai Medical Center, USA. | |
| 2023-present | Associate Director, The Center for Artificial Intelligence Research and Education, Cedars-Sinai Medical Center, USA. | |
| 2023-present | Director, Urologic Oncology Bioinformatics, Cedars-Sinai Medical Center, USA | |
| 2022-2025 | Associate Professor, Departments of Urology and Computational Biomedicine, Cedars-Sinai Medical Center, USA. | |
| 2017-2022 | Assistant Professor, Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, USA. | |
| 2014-2017 | Instructor, Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, USA. | |
Computational frameworks for enhanced extracellular vesicle biomarker discovery
Extracellular vesicles (EVs) are emerging as promising noninvasive biomarkers, yet their clinical translation faces substantial hurdles, primarily due to the challenge of identifying assay-compatible markers. Here, in this Review, we outline sophisticated computational frameworks, particularly leveraging artificial intelligence, to bridge this gap. We detail the integration of diverse data resources, including disease-specific omics, EV, protein localization, tissue-specific, drug, model system and immune databases. This Review comprehensively describes computational selection strategies, from rule-based sequential filtering to advanced machine learning for data fusion and deep learning for multi-omics integration. Crucially, it discusses the refinement of biomarker candidates using artificial-intelligence-driven predictions of protein structure and physicochemical properties, ensuring compatibility with existing assay systems. By systematically evaluating biomarkers for predictive performance, biological plausibility and clinical utility, this framework aims to accelerate the transition of EV research from discovery to clinical application, thereby enhancing precision medicine.
Exp Mol Med. 2026 Feb;58(1):73-81. doi: 10.1038/s12276-025-01622-x.
https://pubmed.ncbi.nlm.nih.gov/41535547/